Bruno J. Gonzalez mainly focuses on Cerebellum, Receptor, Cell biology, Internal medicine and Endocrinology. His study in the fields of Cerebellar cortex under the domain of Cerebellum overlaps with other disciplines such as Granule cell. His work on Receptor deals in particular with Vasoactive intestinal peptide and Neuropeptide.
In general Vasoactive intestinal peptide study, his work on Pituitary adenylate cyclase-activating peptide often relates to the realm of Endocrine gland, thereby connecting several areas of interest. His work is dedicated to discovering how Cell biology, Apoptosis are connected with Neuroprotection and other disciplines. His work in Somatostatin receptor and Somatostatin are all subfields of Internal medicine research.
His scientific interests lie mostly in Internal medicine, Endocrinology, Cerebellum, Receptor and Granule cell. In his study, Fetal alcohol syndrome and Angiogenesis is inextricably linked to Fetus, which falls within the broad field of Internal medicine. Bruno J. Gonzalez works mostly in the field of Endocrinology, limiting it down to topics relating to Pituitary adenylate cyclase-activating peptide and, in certain cases, Molecular biology, as a part of the same area of interest.
His Cerebellum study combines topics from a wide range of disciplines, such as Neurite, Central nervous system and Cell biology. His study looks at the intersection of Cell biology and topics like Apoptosis with Neuroprotection. His Receptor research is multidisciplinary, relying on both Neurogenesis and Binding site.
Internal medicine, Endocrinology, NMDA receptor, Angiogenesis and Neuroprotection are his primary areas of study. His research is interdisciplinary, bridging the disciplines of Fetus and Internal medicine. In his research, Bruno J. Gonzalez performs multidisciplinary study on Endocrinology and Intracerebral hemorrhage.
His NMDA receptor research incorporates themes from Glutamate receptor, Glutamatergic, Cell biology and Cortex, Neuroscience. The concepts of his Cortex study are interwoven with issues in Receptor, Matrix metalloproteinase and GRIN1. The Neuroprotection study combines topics in areas such as Lesion and GABAergic.
Bruno J. Gonzalez mostly deals with Angiogenesis, Pharmacology, Neuroprotection, NMDA receptor and Endocrinology. Bruno J. Gonzalez has included themes like Fetal alcohol syndrome, Tyrosine kinase and Programmed cell death in his Angiogenesis study. His work carried out in the field of Pharmacology brings together such families of science as Neuroendocrine tumors, Viability assay, Pheochromocytoma, CD31 and Sunitinib.
His work in Neuroprotection covers topics such as GABAergic which are related to areas like gamma-Aminobutyric acid and Glutamate receptor. Bruno J. Gonzalez usually deals with NMDA receptor and limits it to topics linked to Glutamatergic and Ex vivo, ATG5, Excitotoxicity, Developmental profile and Antagonist. His work focuses on many connections between Endocrinology and other disciplines, such as Internal medicine, that overlap with his field of interest in In utero.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
David Vaudry;Bruno J. Gonzalez;Magali Basille;Laurent Yon.
Pharmacological Reviews (2000)
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis.
D. Vaudry;T. F. Pamantung;M. Basille;C. Rousselle.
European Journal of Neuroscience (2002)
Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts.
B.J Gonzalez;M Basille;D Vaudry;A Fournier.
Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development
David Vaudry;Bruno J. Gonzalez;Magali Basille;Alain Fournier.
Proceedings of the National Academy of Sciences of the United States of America (1999)
The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
David Vaudry;Bruno J. Gonzalez;Magali Basille;Tommy F. Pamantung.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death
David Vaudry;Cécile Rousselle;Magali Basille;Anthony Falluel-Morel.
Proceedings of the National Academy of Sciences of the United States of America (2002)
VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells.
Michèle Cazillis;Bruno J. Gonzalez;Claude Billardon;Alain Lombet.
European Journal of Neuroscience (2004)
Expression of a complete and functional complement system by human neuronal cells in vitro
Anne Thomas;Philippe Gasque;David Vaudry;Bruno Gonzalez.
International Immunology (2000)
Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway.
D Vaudry;B.J Gonzalez;M Basille;Y Anouar.
The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways
Aurélia Ravni;Steve Bourgault;Steve Bourgault;Alexis Lebon;Philippe Chan.
Journal of Neurochemistry (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: